Barclays raised UnitedHealth's target price to $655.
UnitedHealth Is Maintained at Overweight by Barclays
UnitedHealth Group Analyst Ratings
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $610
UnitedHealth's Strategic Outlook Reinforces Buy Rating Amidst Positive Medicare Insights and Growth Visibility
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $655
RBC Capital Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $655
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $603
Barclays Reaffirms Their Buy Rating on UnitedHealth (UNH)
Wells Fargo Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $677
Wells Fargo Adjusts Price Target on UnitedHealth to $677 From $630, Maintains Overweight Rating
Wells Fargo Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $630
Wells Fargo Keeps Their Buy Rating on UnitedHealth (UNH)
Is UnitedHealth Group Stock (NYSE:UNH) a Buy on the Dip?
UnitedHealth Is Maintained at Overweight by Barclays
UnitedHealth Group Analyst Ratings
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $603
Barclays Reaffirms Their Buy Rating on UnitedHealth (UNH)
UnitedHealth Group Analyst Ratings
TD Cowen Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $609